No Data
No Data
Xin Yuan Enterprises in Turmoil as Chairman Ousted Amid Leadership Conflict
XIN YUAN ENT (01748.HK): Chen Jiagan has been appointed as the Chairman of the Board of Directors and the Chairman of the Company's Nomination Committee.
On December 17, Gelonghui announced that Chen Jiagan, an executive director and vice chairman of the Board of Directors of XIN YUAN ENT (01748.HK), has been appointed as the chairman of the Board of Directors and chairman of the company's nomination committee, effective from December 17, 2024. After the appointment of Chen Jiagan, he will no longer serve as the vice chairman of the Board of Directors, while Chen Ming will no longer serve as the chairman and chairman of the nomination committee. Chen Ming will continue to serve as an executive director and a member of the company's Global Strategy Development Committee.
LUYE PHARMA (02186.HK) has completed the issuance of 50 million US dollars in convertible Bonds with an interest rate of 5.85%.
LUYE PHARMA (02186.HK) announced that all conditions precedent for the issuance of 50 million USD convertible Bonds with a 5.85% interest rate maturing in 2025 have been fulfilled, and the issuance of the related Bonds has been successfully completed. It is expected that the related Bonds will be traded on the Singapore Exchange starting today (16th). LUYE PHARMA stated that this issuance can improve the group's liquidity and replace some short-term loans, with the net proceeds from the issuance of Bonds reducing the group's cost of capital and improving the debt maturity situation. (js/w)~
XIN YUAN ENT (01748): Claims that the petitioner demands to convene a special Shareholder meeting to remove and appoint Directors.
XIN YUAN ENT (01748) announced that on December 13, 2024, the company's Board of Directors (Board of Directors...
XIN YUAN ENT: 2024 Interim Report
Major bank rating | JPMorgan: Industry forecasts show that future shipping demand will slow down in the coming months, lowering Orient Overseas target price to HK$166.
According to the industry forecast, the demand is expected to slow down in the coming months, but it is anticipated that freight rates in the fourth quarter will not have a significant adjustment. Looking ahead to 2025, the industry's supply and demand imbalance situation may improve.
No Data